Home › Bristol-Myers Squibb To Acquire Padlock Therapeutics, Inc.
 

Keywords :   


Bristol-Myers Squibb To Acquire Padlock Therapeutics, Inc.

2016-03-30 03:53:43| drugdiscoveryonline Home Page

Bristol-Myers Squibb Company and Padlock Therapeutics, Inc. announced recently that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the outstanding capital stock of Padlock, a private, Cambridge, Massachusetts-based biotechnology company dedicated to creating new medicines to treat destructive autoimmune diseases

Tags: acquire therapeutics squibb padlock

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
01.07Union expected to call off Port Talbot strike action
01.07Mentorship in Motion
01.07Farm Progress America, July 1, 2024
01.07Hurricane Beryl Forecast Discussion Number 11
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Wind Speed Probabilities Number 11
01.07Hurricane Beryl Forecast Advisory Number 11
01.07Hurricane Beryl Public Advisory Number 11
More »